CTIS2022-502821-16-00招募中1 期
A randomized, placebo controlled, investigator and participant-blinded study, investigating safety, tolerability and efficacy of RHH646 in participants with knee osteoarthritis - CRHH646A12201
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Participant is >/= 35 and lateral Joint Space Narrowing (latJSN) in the target knee evaluated by X-Ray by the Central Reader at screening, Symptomatic disease, defined as having pain in the knee at least 3 days per week during the last 3 months from screening that is relieved by analgesic therapy (e.g., APAP or NSAIDs), according to the investigator’s evaluation and judgement of patient’s history
排除标准
- •Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, Inability to undergo MRI (e.g. claustrophobia, body size, leg not fitting in the coil) or contraindications to MRI (e.g. non-MRI compatible metallic implants, metallic foreign bodies, pacemaker, defibrillator), Arthroscopy of the target knee within the 6 months prior to screening or planned arthroscopy during the study, Previous surgical treatment of the target knee using mosaicplasty, microfracture, meniscectomy >50% or osteotomy; planned surgery for either knee during the study, Unstable target knee joint or insufficiently reconstructed ligaments based on medical history and/or physical examination by the investigator, Participant has severe malalignment (valgus or varus deformity) in the target knee >7.5° based on X-Ray evaluation by the Central Reader at screening, K&L grade 4 OA in either knee, Presence of severe hip OA that either (i) alters lower limb function to a degree that increases or abnormally changes the mechanical forces in the knee while walking according to the investigator’s evaluation or (ii) currently requires or is likely to require specific medical or surgical management during the study period, Other pathologies affecting the knee, including subchondral insufficiency fractures, bone fracture (acute or subacute within the 6 months prior to screening) or bone bruise, osteonecrosis, malignant bone marrow infiltration, solid tumors and/or patellofemoral dysplasia bbased on clinical assessment or imaging, Known autoimmune disease with inflammatory arthritis, crystal-induced arthritides (gout or pseudogout arthritis), active acute or chronic infection of the knee joint, Lyme disease involving the knee, reactive arthritis, systemic cartilage disorders, moderate to severe fibromyalgia, a known systemic connective tissue disease or a widespread pain index >4
研究者
相似试验
进行中（未招募）
1 期
Study with HSY244 to restore normal heart rhythm in people with atrial fibrillatioAtrial FibrillationEUCTR2020-004327-17-DEovartis Pharma AG13
进行中（未招募）
2 期
RAD in the Treatment of Pulmonary FibrosisRespiratory - Other respiratory disorders / diseasesPulmonary FibrosisACTRN12605000599673Dr Monique Malouf120
已完成
不适用
A randomized, placebo controlled, subject and investigator blinded, first-in-human, single ascending dose study to evaluate the safety, tolerability, and pharmacokinetics after intra-articular injection of LRX712 into the knee of osteoarthritic patients.NL-OMON46705ovartis42
尚未招募
3 期
Investigator-initiated, placebo-controlled, randomized trial to assess the efficacy and safety of platelet inhibition and/ or lipid lowering in non-ACS-patients with elevated high-sensitivity troponin valuesDRKS00017671niversitäres Herzzentrum Hamburg3,000
进行中（未招募）
1 期
A placebo-controlled, randomized trial evaluating the efficacy and safety of acetylsalicylic acid and atorvastatin in patients at risk for cardiovascular diseaseMyocardial IschemiaMedDRA version: 20.0Level: LLTClassification code 10028601Term: Myocardial ischemiaSystem Organ Class: 100000004849EUCTR2019-002833-12-DEniversity Medical Centre Hamburg-Eppendorf3,000